LSL Pharma Group Inc. (TSXV:LSL)

Canada flag Canada · Delayed Price · Currency is CAD
0.3450
+0.0050 (1.47%)
Apr 24, 2025, 4:00 PM EDT
-13.75%
Market Cap 40.44M
Revenue (ttm) 15.82M
Net Income (ttm) -2.45M
Shares Out 115.53M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,500
Average Volume 45,682
Open 0.3450
Previous Close 0.3400
Day's Range 0.3350 - 0.3450
52-Week Range 0.2900 - 0.5500
Beta -0.47
RSI 55.50
Earnings Date Feb 28, 2025

About LSL Pharma Group

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. It offers dietary supplements and vitamins in the tablet and capsule form; and niche sterile ophthalmic products in the form of ointments and drops for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada. [Read more]

Sector Healthcare
CEO Francois Roberge
Employees 114
Stock Exchange TSX Venture Exchange
Ticker Symbol LSL
Full Company Profile

Financial Performance

In 2023, LSL Pharma Group's revenue was 10.03 million, an increase of 22.08% compared to the previous year's 8.21 million. Losses were -8.47 million, 5.09% more than in 2022.

Financial Statements

News

There is no news available yet.